TY - CHAP
T1 - Percutaneous coronary intervention strategy of coronary bypass graft failure
AU - Wu, Cho Kai
AU - Hwang, Juey Jen
AU - Lin, Jiunn-Lee
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Saphenous vein graft (SVG) lesions remain one of the most challenging problems for interventional cardiologists. Procedures performed in patients with SVG lesions are often more complex and are associated with higher risk than those in patients with native vessel percutaneous coronary intervention (PCI). Long-term benefi ts are also limited in this condition. There are several factors infl uencing the outcomes of SVG PCI including (1) diffi culties in graft localization and engagement, (2) high rates of periprocedural myocardial infarction (MI) caused by distal embolization in SVGs, and (3) high restenosis rates. However, PCI is generally preferred instead of surgical revascularization. Factors favoring PCI include limited areas of ischemia causing symptoms, suitable PCI targets, a patent graft to the left anterior descending artery (LAD), poor coronary artery bypass graft (CABG) targets, and comorbid conditions.
AB - Saphenous vein graft (SVG) lesions remain one of the most challenging problems for interventional cardiologists. Procedures performed in patients with SVG lesions are often more complex and are associated with higher risk than those in patients with native vessel percutaneous coronary intervention (PCI). Long-term benefi ts are also limited in this condition. There are several factors infl uencing the outcomes of SVG PCI including (1) diffi culties in graft localization and engagement, (2) high rates of periprocedural myocardial infarction (MI) caused by distal embolization in SVGs, and (3) high restenosis rates. However, PCI is generally preferred instead of surgical revascularization. Factors favoring PCI include limited areas of ischemia causing symptoms, suitable PCI targets, a patent graft to the left anterior descending artery (LAD), poor coronary artery bypass graft (CABG) targets, and comorbid conditions.
KW - Antithrombotic
KW - Baremetal stent (BMS)
KW - Covered stent
KW - Direct stenting
KW - Distal embolization
KW - Drug-eluting stent (DES)
KW - Embolic protection device (EPD)
KW - Glycoprotein inhibitor
KW - Percutaneous coronary intervention (PCI)
KW - Saphenous vein graft (SVG)
KW - Thrombus
KW - Vasodilator
KW - Vein graft disease
UR - http://www.scopus.com/inward/record.url?scp=84978221282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978221282&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-26515-5_62
DO - 10.1007/978-3-319-26515-5_62
M3 - Chapter
AN - SCOPUS:84978221282
SN - 9783319265131
SP - 683
EP - 688
BT - Coronary Graft Failure
PB - Springer International Publishing
ER -